New US president Joe Biden has pledged to release altogether $4 billion in US funding to support Gavi, the global vaccine alliance. The president was expected to announce...
Sandoz, the generics division of Swiss drugmaker Novartis, is picking up GlaxoSmithKline’s cephalosporin antibiotics business, including the brands Zinnat, Zinacef and...
The EU appears to be close to signing a Covid-19 vaccine supply deal with US biotech manufacturer Novavax. The Reuters news agency cites two EU officials involved in...
Pfizer and BioNTech are accelerating the time it takes to produce a Covid-19 vaccine batch and are aiming to almost cut it in half, Chaz Calitri, vice president of...
Conventional drugmakers are now responding in force to the Covid-19 vaccine challenge, teaming up on different projects with different partners, contributing expertise...
Vaccines and treatments for Covid-19 continue to dominate global pharma market headlines. As the pandemic drags on, new issues continuously arise, some of them...
With news of an EU Covid-19 vaccine shortage dominating international headlines, another European player is stepping up to try to bridge the gap. On the heels of French...
For months, pandemic watchers have weighed in on the potential inequity of vaccine distribution, focusing mainly on the First World hoarding supplies that Third World...
French drugmaker Sanofi has named its new company for major Active Pharmaceutical ingredients EuroAPI and announced Karl Rotthier as its future CEO with effect from Jan...
French pharma Sanofi is once again boosting its immunotherapy capabilities, this time with the acquisition of UK biotech Kymab. The company will make an upfront payment...
